TLR4 c.715_716delinsGA ;(p.S239D)

Variant ID: 9-120475121-AG-GA

NM_138554.4(TLR4):c.715_716delinsGA;(p.S239D)

This variant was identified in 3 publications

View GRCh38 version.




Publications:


The role of IgG Fc receptors in antibody-dependent enhancement.

Nature Reviews. Immunology
Bournazos, Stylianos S; Gupta, Aaron A; Ravetch, Jeffrey V JV
Publication Date: 2020-10

Variant appearance in text: TLR4: S239D
PubMed Link: 32782358
Variant Present in the following documents:
  • Main text
View BVdb publication page



IgG Fc engineering to modulate antibody effector functions.

Protein & Cell
Wang, Xinhua X; Mathieu, Mary M; Brezski, Randall J RJ
Publication Date: 2018-01

Variant appearance in text: TLR4: S239D
PubMed Link: 28986820
Variant Present in the following documents:
  • Main text
  • 13238_2017_Article_473.pdf
View BVdb publication page



Enhancement of antibody-dependent cell mediated cytotoxicity: a new era in cancer treatment.

Immunotargets And Therapy
Rajasekaran, Narendiran N; Chester, Cariad C; Yonezawa, Atsushi A; Zhao, Xing X; Kohrt, Holbrook E HE
Publication Date: 2015

Variant appearance in text: TLR4: S239D
PubMed Link: 27471715
Variant Present in the following documents:
  • Main text
  • itt-4-091.pdf
View BVdb publication page